Fluidigm (NASDAQ:FLDM) Latest News, Stock Price and Trading Information

Oncology Researcher Andrew Quong Joins Fluidigm as Chief Science Officer

Globe Newswire 4-Jun 8:30 AM

Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Globe Newswire 31-May 5:37 PM

Fluidigm Introduces Advanta RNA Fusions NGS Library Prep Assay to Accelerate Translational and Clinical Cancer Research

Globe Newswire 29-May 8:45 AM

Fluidigm Introduces Automated Advanta Solid Tumor NGS Library Prep Assay Using Microfluidics Technology

Globe Newswire 29-May 8:31 AM

Fluidigm to Participate in Upcoming Health Care Investor Conferences

Globe Newswire 9-May 8:31 AM

Fluidigm Announces First Quarter 2019 Financial Results

Globe Newswire 2-May 4:05 PM

Leading Cancer Center in Japan Selects Hyperion Imaging System to Expand Immuno-Oncology Research Studies in Colorectal Cancer

Globe Newswire 2-May 4:02 PM

Fluidigm Announces 8th Annual Mass Cytometry Summit

Globe Newswire 30-Apr 9:02 AM

Fluidigm Announces Conference Call and Webcast of First Quarter 2019 Financial Results

Globe Newswire 4-Apr 4:05 PM

Recent Analysis Shows Newell Brands, NorthStar Realty Europe, Advanced Disposal Services, Fluidigm, Huron Consulting Group, and Healthcare Realty Trust Market Influences Renewed Outlook, Key Drivers of Growth

Globe Newswire 3-Apr 7:45 AM

Fluidigm Introduces the First Complete Sample-to-Answer Solution for Deep Immune Profiling by Mass Cytometry

Globe Newswire 28-Mar 8:31 AM